Your session is about to expire
← Back to Search
Microfluidics Device
ZyMot Multi Sperm Separation Device (850 ul) for Assisted Reproductive Technology
N/A
Waitlist Available
Led By Rani Fritz, DO, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Use or possible use of ICSI for oocyte insemination
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up culture day 5 or 6
Awards & highlights
Study Summary
This trial will compare the success of two different methods of separating sperm for ICSI.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You may have used or plan to use a specific method called ICSI for fertilization of eggs.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ culture day 5 or 6
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~culture day 5 or 6
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percentage of Good Quality Blastocyst Formation
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ZyMot SeparationExperimental Treatment1 Intervention
Treatment
Group II: Density Gradient CentrifugationActive Control1 Intervention
Control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ZyMot Multi Sperm Separation Device (850 ul)
2021
N/A
~110
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,358 Previous Clinical Trials
816,705 Total Patients Enrolled
Rani Fritz, DO, PhDPrincipal InvestigatorNYU Langone Health
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still vacancies available for individuals to join this clinical endeavor?
"Data available on clinicaltrials.gov suggests that the recruitment phase of this trial is complete; it was first published on June 18th 2021 and last updated 6/6/2022. However, there are presently 9 other trials actively seeking patients at this time."
Answered by AI
Who else is applying?
What site did they apply to?
NYU Langone Reproductive Specialists of NY
What portion of applicants met pre-screening criteria?
Met criteria
Why did patients apply to this trial?
don't want to provide my SSN to a random website.
PatientReceived 2+ prior treatments
Share this study with friends
Copy Link
Messenger